BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16556153)

  • 1. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
    Pescovitz MD
    Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The (re)emergence of B cells in organ transplantation.
    Stegall MD; Raghavaiah S; Gloor JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):451-5. PubMed ID: 20613525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of donor-specific alloantibody.
    Turgeon NA; Kirk AD; Iwakoshi NN
    Transplant Rev (Orlando); 2009 Jan; 23(1):25-33. PubMed ID: 18951778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
    Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
    J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming Chronic Rejection-Can it B?
    Kwun J; Knechtle SJ
    Transplantation; 2009 Oct; 88(8):955-61. PubMed ID: 19855237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
    Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
    Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence for a role of allograft accommodation in long-term tolerance.
    Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
    Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody-mediated acute rejection].
    Lefaucheur C; Nochy D; Glotz D
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac antibody-mediated rejection.
    Chin C
    Pediatr Transplant; 2012 Aug; 16(5):404-12. PubMed ID: 22500558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of rituximab in organ transplantation.
    Becker YT; Samaniego-Picota M; Sollinger HW
    Transpl Int; 2006 Aug; 19(8):621-8. PubMed ID: 16827678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA alloantibodies in pediatric solid organ transplantation.
    Girnita AL; Webber SA; Zeevi A
    Pediatr Transplant; 2006 Mar; 10(2):146-53. PubMed ID: 16573598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell monitoring of transplant patients treated with anti-CD20.
    Abdallah KO; Prak ET
    Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and role of HLA and non-HLA alloantibodies.
    Tinckam KJ; Chandraker A
    Clin J Am Soc Nephrol; 2006 May; 1(3):404-14. PubMed ID: 17699239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.